These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2776893)

  • 1. Disappearance of exogenously administered human chorionic gonadotropin.
    Damewood MD; Shen W; Zacur HA; Schlaff WD; Rock JA; Wallach EE
    Fertil Steril; 1989 Sep; 52(3):398-400. PubMed ID: 2776893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can in vitro fertilization cycles be salvaged by repeat administration of intramuscular human chorionic gonadotropin the day after failed injection?
    Reichman DE; Greenwood E; Meyer L; Kligman I; Rosenwaks Z
    Fertil Steril; 2012 Sep; 98(3):671-4. PubMed ID: 22769734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization--embryo transfer using human menopausal gonadotropin and intracytoplasmic sperm injection.
    Elkind-Hirsch KE; Bello S; Esparcia L; Phillips K; Sheiko A; McNichol M
    Fertil Steril; 2001 Apr; 75(4):700-4. PubMed ID: 11287022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamics and pharmacokinetics after subcutaneous and intramuscular injection of human chorionic gonadotropin.
    Saal W; Glowania HJ; Hengst W; Happ J
    Fertil Steril; 1991 Aug; 56(2):225-9. PubMed ID: 1712735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction.
    Araujo E; Bernardini L; Frederick JL; Asch RH; Balmaceda JP
    J Assist Reprod Genet; 1994 Feb; 11(2):74-8. PubMed ID: 7819706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous versus intramuscular administration of human chorionic gonadotropin during an in vitro fertilization cycle.
    Stelling JR; Chapman ET; Frankfurter D; Harris DH; Oskowitz SP; Reindollar RH
    Fertil Steril; 2003 Apr; 79(4):881-5. PubMed ID: 12749424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes.
    Laufer N; DeCherney AH; Tarlatzis BC; Zuckerman AL; Polan ML; Dlugi AM; Graebe R; Barnea ER; Naftolin F
    Fertil Steril; 1984 Aug; 42(2):198-203. PubMed ID: 6430722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of human chorionic gonadotropin injection in obese and normal-weight women.
    Shah DK; Missmer SA; Correia KF; Ginsburg ES
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1314-21. PubMed ID: 24476082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomized study of the optimum timing of human chorionic gonadotropin administration after pituitary desensitization in in vitro fertilization.
    Tan SL; Balen A; el Hussein E; Mills C; Campbell S; Yovich J; Jacobs HS
    Fertil Steril; 1992 Jun; 57(6):1259-64. PubMed ID: 1601148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peri-ovarian adhesions interfere with the diffusion of gonadotrophin into the follicular fluid.
    Nagata Y; Honjou K; Sonoda M; Makino I; Tamura R; Kawarabayashi T
    Hum Reprod; 1998 Aug; 13(8):2072-6. PubMed ID: 9756271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of human chorionic gonadotropin after i.m. administration in goats (Capra hircus).
    Saleh M; Shahin M; Wuttke W; Gauly M; Holtz W
    Reproduction; 2012 Jul; 144(1):77-81. PubMed ID: 22573828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion.
    Marrs RP; Kletzky OA; Howard WF; Mishell DR
    Am J Obstet Gynecol; 1979 Nov; 135(6):731-6. PubMed ID: 495673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periovulatory serum human chorionic gonadotropin (hCG) concentrations following subcutaneous and intramuscular nonrecombinant hCG use during ovulation induction: a prospective, randomized trial.
    Sills ES; Drews CD; Perloe M; Kaplan CR; Tucker MJ
    Fertil Steril; 2001 Aug; 76(2):397-9. PubMed ID: 11476796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Falling estradiol levels on day after human chorionic gonadotropin administration in assisted reproductive technology cycles are not predictive of decreasing oocyte maturity or pregnancy rates.
    Levy G; Hill M; Beall S; Pilgrim JD; Payson M; Propst A
    J Reprod Med; 2014; 59(5-6):255-9. PubMed ID: 24937966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial.
    Engmann LL; Maslow BS; Kaye LA; Griffin DW; DiLuigi AJ; Schmidt DW; Grow DR; Nulsen JC; Benadiva CA
    J Ovarian Res; 2019 Jan; 12(1):8. PubMed ID: 30684970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective randomized trial.
    Kyrou D; Kolibianakis EM; Fatemi HM; Tarlatzis BC; Tournaye H; Devroey P
    Fertil Steril; 2011 Nov; 96(5):1112-5. PubMed ID: 21924414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone/estradiol ratio <0.25 on the day of human chorionic gonadotropin administration is associated with adverse pregnancy outcomes in prolonged protocols for in vitro fertilization/intracytoplasmic sperm injection.
    Li Y; Luo K; Tang Y; Lin G; Lu G; Gong F
    Taiwan J Obstet Gynecol; 2017 Feb; 56(1):27-31. PubMed ID: 28254221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized three-way cross-over study in healthy pituitary-suppressed women to compare the bioavailability of human chorionic gonadotrophin (Pregnyl) after intramuscular and subcutaneous administration.
    Mannaerts BM; Geurts TB; Odink J
    Hum Reprod; 1998 Jun; 13(6):1461-4. PubMed ID: 9688371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between serum human chorionic gonadotrophin levels and body mass index in women undergoing in vitro fertilisation cycles.
    Stefanis P; Das S; Barsoum-Derias E; Kingsland C; Lewis-Jones I; Gazvani R
    Eur J Obstet Gynecol Reprod Biol; 2007 Jun; 132(2):204-8. PubMed ID: 17011694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.